Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Phase II trial design with growth modulation index as the primary endpoint.

Wu J, Chen L, Wei J, Weiss H, Miller RW, Villano JL.

Pharm Stat. 2019 Mar;18(2):212-222. doi: 10.1002/pst.1916. Epub 2018 Nov 20.

PMID:
30458583
2.

Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

van Nagell JR Jr, Burgess BT, Miller RW, Baldwin L, DeSimone CP, Ueland FR, Huang B, Chen Q, Kryscio RJ, Pavlik EJ.

Obstet Gynecol. 2018 Nov;132(5):1091-1100. doi: 10.1097/AOG.0000000000002921.

PMID:
30303916
3.

Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.

Ore RM, Chen Q, DeSimone CP, Miller RW, Baldwin LA, van Nagell JR Jr, Huang B, Tucker TC, Johnson MS, Fredericks TI, Ueland FR.

South Med J. 2018 Jun;111(6):333-341. doi: 10.14423/SMJ.0000000000000821.

PMID:
29863220
4.

Symptoms Relevant to Surveillance for Ovarian Cancer.

Ore RM, Baldwin L, Woolum D, Elliott E, Wijers C, Chen CY, Miller RW, DeSimone CP, Ueland FR, Kryscio RJ, Nagell JR, Pavlik EJ.

Diagnostics (Basel). 2017 Mar 20;7(1). pii: E18. doi: 10.3390/diagnostics7010018.

5.

Complications from Surgeries Related to Ovarian Cancer Screening.

Baldwin LA, Pavlik EJ, Ueland E, Brown HE, Ladd KM, Huang B, DeSimone CP, van Nagell JR, Ueland FR, Miller RW.

Diagnostics (Basel). 2017 Mar 8;7(1). pii: E16. doi: 10.3390/diagnostics7010016.

6.

Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.

Lefringhouse JR, Elder JW, Baldwin LA, Miller RW, DeSimone CP, van Nagell JR Jr, Samoyoa LM, West DS, Dressler EV, Liu M, Ueland FR.

Gynecol Oncol. 2017 Apr;145(1):50-54. doi: 10.1016/j.ygyno.2017.01.032. Epub 2017 Feb 9.

PMID:
28190648
7.

Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.

Lefringhouse JR, Neward E, Ueland FR, Baldwin LA, Miller RW, DeSimone CP, Kryscio RJ, van Nagell JR, Pavlik EJ.

Womens Health (Lond). 2016 Jun;12(3):303-11. doi: 10.2217/whe.15.111. Epub 2016 May 18.

8.

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.

Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR Jr, Ueland FR.

Gynecol Oncol. 2014 Oct;135(1):8-12. doi: 10.1016/j.ygyno.2014.07.091. Epub 2014 Jul 25.

PMID:
25068975
9.

The effect of ovarian imaging on the clinical interpretation of a multivariate index assay.

Goodrich ST, Bristow RE, Santoso JT, Miller RW, Smith A, Zhang Z, Ueland FR.

Am J Obstet Gynecol. 2014 Jul;211(1):65.e1-65.e11. doi: 10.1016/j.ajog.2014.02.010. Epub 2014 Feb 12.

PMID:
24530816
10.

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.

Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7. doi: 10.1097/AOG.0b013e318298def5.

PMID:
23969786
11.

Ovarian cyst fluids are a cache of tumor biomarkers that include calgranulin A and calgranulin B isoforms.

Skaggs HS, Saunders BA, Miller RW, Goodrich ST, King MS, Kimbler KD, Branscum AJ, Fung ET, DePriest PD, van Nagell JR, Ueland FR, Baron AT.

Cancer Invest. 2013 Aug;31(7):433-53. doi: 10.3109/07357907.2013.802799.

PMID:
23915068
12.

Ten-year relative survival for epithelial ovarian cancer.

Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG.

Obstet Gynecol. 2012 Sep;120(3):612-8.

PMID:
22914471

Supplemental Content

Loading ...
Support Center